Literature Pentixafor

[1] Gourni E et al. PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent. J Nucl Med, 2011, 52(11):1803-10.
Link: http://jnm.snmjournals.org/content/52/11/1803.long

[2] Wester HJ et al. Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging. Theranostics, 2015, 1;5(6):618-30.
Link: http://www.thno.org/v05p0618.htm

[3] Herrmann K. et al. Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor. J Nucl Med. 2015, 56(3):410-6.
Link: http://jnm.snmjournals.org/content/56/3/410.long

[4] Walenkamp AM et al. CXCR4 Ligands: The Next Big Hit? J Nucl Med. 2017 58(Suppl 2):77S-82S.
Link: http://jnm.snmjournals.org/content/58/Supplement_2/77S.long

[5] Ripschler C. et al. Upregulated myocardial CXCR4-expressionafter myocardial infarction assessed by simultaneous GA-68 pentixafor PET/MRI J Nucl Cardiol. 2016 23(1):131-133
Link: https://link.springer.com/article/10.1007%2Fs12350-015-0347-5

[6] Lapa C. et al. 68Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma, Theranostics. 2016 6(3):428-434
Link: http://www.thno.org/v06p0428.htm

[7] Tackeray JT. et al. Molecular Imaging of the Chemokine Receptor CXCR4 After Acute Myocardial Infarction, JACC Cardiovasc Imaging, 2015 8(12):1417-1426
Link: https://www.sciencedirect.com/science/article/pii/S1936878X15007597?via%3Dihub

[8] Vag T. et al. First Experience on Chemokine Receptor CXCR4 Targeted Positron Emission Tomography (PET) Imaging in Patients with Solid Cancers, J Nucl Med, 2016 57(5):741-746
Link: http://jnm.snmjournals.org/content/57/5/741.long